✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Dishman Carbogen Amcis Ltd.

DCAL

Market Cap
₹3,376 Cr.
P/E
0.00

Dishman Carbogen Amcis Ltd.

  • Dishman Carbogen Amc
  • Sun Pharma Adv. Res
  • Zenotech Laboratorie
  • TJI Pharma - Small Cap
FAQs on Dishman Carbogen Amcis Ltd. Shareprice

Dishman Carbogen Amc has given lower returns compared to its competitors.
Dishman Carbogen Amc has grown at ~-6.52% over the last 7yrs while peers have grown at a median rate of 1.39%

Dishman Carbogen Amc is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Dishman Carbogen Amc is 0.0, while 3 year average PE is 28.77.
Also latest EV/EBITDA of Dishman Carbogen Amc is 13.32 while 3yr average is 13.08.

View FAQ's On Business
Growth Table
  • Dishman Carbogen Amcis Ltd.
  • Sun Pharma Adv. Res
  • Zenotech Laboratorie
Balance Sheet
  • Dishman Carbogen Amcis Ltd.
  • Sun Pharma Adv. Res
  • Zenotech Laboratorie
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Dishman Carbogen Amcis Ltd.
  • Sun Pharma Adv. Res
  • Zenotech Laboratorie
Cash Flow
  • Dishman Carbogen Amcis Ltd.
  • Sun Pharma Adv. Res
  • Zenotech Laboratorie
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Dishman Carbogen Amcis Ltd.
  • Sun Pharma Adv. Res
  • Zenotech Laboratorie
Quarterly Results
  • Dishman Carbogen Amcis Ltd.
  • Sun Pharma Adv. Res
  • Zenotech Laboratorie
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Dishman Carbogen Amcis Ltd. Financials

Dishman Carbogen Amc balance sheet is weak and might have solvency issues

Yes, The debt of Dishman Carbogen Amc is increasing.
Latest debt of Dishman Carbogen Amc is ₹1,773 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹1,138 Crs.

The profit is oscillating.
The profit of Dishman Carbogen Amc is -₹109.77 Crs for TTM, -₹153.45 Crs for Mar 2024 and -₹29.8 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Dishman Carbogen Amc latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Inventory

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech